日本語 
Perplexity AI, Inc. and the National Health Foundation have signed a strategic partnership agreement aimed at building next-generation medical AI infrastructure in Japan.
The partnership is centered around something that has become a major issue globally in healthcare AI right now. Data control. Japan seeks to acquire advanced artificial intelligence technology while maintaining its requirement that medical data must remain under its domestic control rather than being transferred to foreign systems which lack proper supervision.
That is where this collaboration is positioning itself.
Also Read: CoreTissue Launches ACL Clinical Cohort Study
Perplexity AI, Inc. will provide AI technology and support healthcare-focused AI services while working inside the framework set by the National Health Foundation. According to the announcement, Japanese personal medical data will remain protected within domestic infrastructure and will not be transmitted to Perplexity. The company also stated it follows a zero-retention policy and does not use customer data for AI model training.
The partnership will focus on multiple areas, including medical AI infrastructure design, integration between Japanese medical LLMs and overseas AI systems, patient health navigation tools, personal health record services, and decision support systems for healthcare professionals. The two sides also plan to run demonstration projects with hospitals and local governments.
The announcement shows a complete transformation of existing practices used by different nations. Countries now consider artificial intelligence implementation and data protection rights as one unified topic instead of two separate matters. The demand for artificial intelligence. Governments want to access advanced artificial intelligence systems while maintaining strict oversight of their handling of confidential information about citizens. Japan is now trying to build both at the same time.
English